Publications by authors named "Meike D Brinker"
Nephrol Dial Transplant
June 2024
Article Synopsis
- Finerenone, a non-steroidal mineralocorticoid receptor antagonist, showed promise in improving kidney and cardiovascular health in patients with chronic kidney disease (CKD) and type 2 diabetes, leading to the FIND-CKD study examining its effects in non-diabetic patients with CKD.
- The FIND-CKD trial is a Phase 3, randomized, double-blind study involving adults with specific eGFR and urinary albumin-creatinine ratio criteria, focused on the efficacy of finerenone versus a placebo over 32 months.
- The trial screened over 3,200 patients, with 1,584 participating; the majority had chronic glomerulonephritis or hypertensive nephrop
